Rapid spread in Norway of an erythromycin-resistant pneumococcal clone, despite low usage of macrolides

Microbial Drug Resistance

Volumn 13, Issue 1, 2007, Pages 29-36

  Sogstad, Maren K R ^a   Littauer, Pia ^b,c   Aaberge, Ingeborg S ^a   Caugant, Dominique A ^a,d   Høiby, E Arne ^a,e  

^a Norwegian Inslitute of Public Health   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MEFA GENE; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NORWAY; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC DISEASE; UNITED KINGDOM;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CHILD; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENOTYPE; HUMANS; MACROLIDES; NORWAY; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 34249715386     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.9994     Document Type: Article

References (43)

1. Ambrose, K.D., R. Nisbet, and D.S. Stephens. 2005. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible. Antimicrob. Agents Chemother. 49:4203-4209.
2. Amezaga, M.R., P.E. Carter, P. Cash, and H. McKenzie. 2002. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J. Clin. Microbiol. 40:3313-3318.
3. Appelbaum, P.C. 2002. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin. Infect. Dis. 34:1613-1620.
4. Arason, V.A., A. Gunnlaugsson, J.A. Sigurdsson, H. Erlendsdottir, S. Gudmundsson, and K.G. Kristinsson. 2002. Clonal spread of resistant pneumococci despite diminished antimicrobial use. Microbial. Drug Resist. 8:187-192.
5. Bean, D.C., and J.D. Klena. 2002. Prevalence of erm(A) and mef(B) erythromycin resistance determinants in isolates of Streptococcus pneumoniae from New Zealand. J. Antimicrob. Chemother. 50:597-599.
6. Brueggemann, A.B., D.T. Griffiths, E. Meats, T. Peto, D.W. Crook, and B.G. Spratt. 2003. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187:1424-1432.
7. Brueggemann, A.B., T.E. Peto, D.W. Crook, J.C. Butler, K.G. Kristinsson, and B.G. Spratt. 2004. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190:1203-1211.
8. Clarke, S.C., J.A. Reid, L. Thom, M.A. Diggle, S. McChlery, K. Scott, and G.F. Edwards. 2005. Erythromycin resistance among invasive pneumococci in Scotland, 1994-2003. Br. J. Biomed. Sci. 62:28-30.
9. Clarke, S.C., K.J. Scott, and S.M. McChlery. 2004. Erythromycin resistance in invasive serotype 14 pneumococci is highly related to clonal type. J. Med. Microbiol. 53:1101-1103.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. 2005. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Cochetti, I., M. Vecchi, M. Mingoia, E. Till, M.R. Catania, A. Manzin, P.E. Varaldo, and M.P. Montanari. 2005. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I). Antimicrob. Agents Chemother. 49:4999-5006.
12. Daly, M.M., S. Doktor, R. Flamm, and D. Shortridge. 2004. Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates. J. Clin. Microbiol. 42:3570-3574.
13. Del Grosso, M., F. Iannelli, C. Messina, M. Santagati, N. Petrosillo, S. Stefani, G. Pozzi, and A. Pantosti. 2002. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774-778.
14. Enright, M.C., and B.G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144: 3049-3060.
15. European Antimicrobial Resistance Surveillance System. EARSS data. Available at www.earss.rivm.nl. Last accessed January 3, 2006.
16. Farrell, D.J., S.G. Jenkins, S.D. Brown, M. Patel, B.S. Lavin, and K.P. Klugman. 2005. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg. Infect. Dis. 11:851-858.
17. Fotopoulou, N., P.T. Tassios, D.V. Beste, S. Ioannidou, A. Efstratiou, HR. Lawrence, J. Papaparaskevas, R.C. George, and N.J. Legakis. 2003. A common clone of erythromycin-resistant Streptococcus pneumoniae in Greece and the UK. Clin. Microbiol. Infect. 9:924-929.
18. Goossens, H., M. Ferech, S.R. Vander, and M. Elseviers. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
19. Granizo, J.J., L. Aguilar, J. Casal, C. Garcia-Rey, R. Dal Re, and F. Baquero. 2000. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J. Antimicrob. Chemother. 46:767-773.
20. Hanage, W.P., T.H. Kaijalainen, R.K. Syrjänen, K. Auranen, M. Leinonen, P.H. Mäkelä, and B.G. Spratt. 2005. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect. Immun. 73:431-435.
21. Klaassen, C.H., and J.W. Mouton. 2005. Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E). Antimicrob. Agents Chemother. 49: 1271-1278.
22. Ko, K.S., and J.H. Song. 2004. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes. J. Infect. Dis. 190:739-747.
23. Littauer, P., M. Sangvik, D.A. Caugant, E.A. Høiby, G.S. Simonsen, and A. Sundsfjord. 2005. Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. J. Clin. Microbiol 43:2125-2132.
24. McGee, L., L. McDougal, J. Zhou, B.G. Spratt, F.C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J.C. Lefevre, A. Tomasz, and K.P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J. Clin. Microbiol. 39:2565-2571.
25. Montanari, M.P., I. Cochetti, M. Mingoia, and P.E. Varaldo. 2003. Phenotypic and molecular characterization of tetracycline-and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:2236-2241.
26. Niederman, M.S., J.B. Bass, Jr., G.D. Campbell, A.M. Fein, R.F. Grossman, L.A. Mandell, T.J. Marrie, G.A. Sarosi, A. Torres, and V.L. Yu. 1993. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am. Rev. Respir. Dis. 148:1418-1426.
27. NORM/NORM-VET 2005. 2005. Consumption of antimicrobial agents and occurrence of antibiotic resistance in Norway. Tromsø/ Oslo: NORM, Avdeling for mikrobiologi, Regionsykehuset i Tromsø.
28. Pedersen, M.K., E.A. Høiby, L.O. Frøholm, V. Hasseltvedt, G. Lermark and D.A. Caugant. 2004. Systemic pneumococcal disease in Norway 1995-2001: capsular serotypes and antimicrobial resistance. Epidemiol. Infect. 132:167-175.
29. Rantala, M., S. Huikko, P. Huovinen, and J. Jalava. 2005. Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002. Antimicrob. Agents Chemother. 49:4180-4184.
30. Reinert, R.R., S. Reinert, L.M. van der, M.Y. Cil, A. Al Lahham, and P. Appelbaum. 2005. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob. Agents Chemother. 49:2903-2913.
31. Roberts, M.C., J. Sutcliffe, P. Courvalin, L.B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolidelincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
32. Sandgren, A., K. Sjostrom, B. Olsson-Liljequist, B. Christensson, A. Samuelsson, G. Kronvall, and N.B. Henriques. 2004. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J. Infect. Dis. 189:785-796.
33. Sangvik, M., P. Littauer, G.S. Simonsen, A. Sundsfjord, and K.H. Dahl. 2005. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J. Antimicrob. Chemother. 56:841-846.
34. Sogstad, M.K., E.A. Hoiby, and D.A. Caugant. 2006. Molecular characterization of non-penicillin-susceptible Streptococcus pneumoniae in Norway. J Clin. Microbiol 44:3225-3230.
35. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
36. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
37. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutcliffe. 1997. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255.
38. Tait-Kamradt, A., T. Davies, P.C. Appelbaum, F. Depardieu, P. Courvalin, J. Petitpas, L. Wondrack, A. Walker, M.R. Jacobs, and J. Sutcliffe. 2000. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44:3395-3401.
39. Tait-Kamradt, A., T. Davies, M. Cronan, M.R. Jacobs, P.C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.
40. Vanderkooi, O.G., D.E. Low, K. Green, J.E. Powis, and A. McGeer. 2005. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin. Infect. Dis. 40:1288-1297.
41. Arason, V.A., A. Gunnlaugsson, J.H. Sigurdsson, H. Erlendsdottir, S. Gudmundsson, and K.G. Kristinsson. 2002. Clonal spread of resistant pneumococci despite diminished antimicrobial use. Microb. Drug Resist. 8:187-192.
42. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797-805.
43. Wierzbowski, A.K., D. Swedlo, D. Boyd, M. Mulvey, K.A. Nichol, D.J. Hoban, and G.G. Zhanel. 2005. Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002. Antimicrob. Agents Chemother. 49:1257-1261.